Diabetes is a chronic disease that makes controlling blood sugar levels challenging. For many individuals, the problem gets worse with time, making blood sugar management more challenging. Semaglutide is one example of GLP-1 receptor agonist that has provided patients with better control ove
According to a study presented at the Endocrine Society's annual meeting in Chicago, the percentage of adults suffering from metabolic-associated fatty liver disease (MAFLD), the leading cause of liver disease worldwide, is increasing.
Diabetes is a chronic condition that makes it difficult to regulate blood sugar levels. For many people, the condition worsens with time, making it harder to control blood sugar levels. Semaglutide is one example of a GLP-1 receptor agonist that has given patients more control over blood sug
Researchers found loneliness is a greater risk factor for heart disease in diabetic patients than diet, exercise, smoking and depression. This research was published in the European Heart Journal, a journal of the European Society of Cardiology (ESC).
Diabetes is a chronic condition that affects one's capacity to regulate blood sugar levels. Many patients' conditions worsen over time, making blood sugar levels more difficult to control. Glucagon-like peptide-1 (GLP-1) receptor agonists, such as semaglutide, have given patients greater con
Researchers found people who develop diabetes after pregnancy were significantly less likely to be able to control it if they had gestational diabetes, especially if they were Black or Hispanic.
Researchers discovered that cancer patients had sweet-smelling urine back in the 1920s. The doctors were first perplexed, but they quickly understood that it was caused by high blood sugar levels.
A research presented on Saturday at ENDO 2023, the Endocrine Society's annual conference in Chicago, Ill, said closed-loop insulin administration devices enhance glucose control in kids with type 1 diabetes without having any negative consequences.
There is a need for urgent state-specific policies and interventions to arrest the rapidly rising epidemic of metabolic non-communicable diseases (NCDs) in India, according to a study conducted by the Indian Council of Medical Research--India Diabetes (ICMR-INDIAB).